Supplement: Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis:  a propensity score-matched cohort study

Name: Supplement: Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study
Creator: Maria Schneeweiss
Published: 2020-10-01T12:56:00.239Z
Keywords: Dermatology, Epidemiology, Safety, Atopic Dermatitis, Conjunctivitis

Schneeweiss, Maria

doi:10.17632/xhfzxp9nfp.1

Supplement: Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study

Published: 1 October 2020| Version 1 | DOI: 10.17632/xhfzxp9nfp.1

Contributor:

Maria Schneeweiss

Description

Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study

Supplement: Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study

Description

Files

Categories

Licence